3Yamaguchi K,Tada M,Horikoshi N,et al.Phase Ⅱ study of paclitaxel with 3-h infusion in patients with advanced gastric cancer[J].Gastric Cancer,2002,5 (2):90-95. 被引量：1
4Kornek GV,Raderer M,Schull B,et al.Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer[J].Br J Cancer,2002,86(12):1858-1863. 被引量：1
5Perez EA,Vogel CL,Irwwin DH,et al.Multicenter phase Ⅱ trial of weekly paclitaxel in women with metastatic breast cancer[J].J Clin Oncol,2001,19(22):4216. 被引量：1
6Likich JJ,Ahlgren JD,Phillips JA,et al.A prospective randomized comparision of continous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma:a midatlantic oncology program study[J].J Clin Oncol,1989,7(8):425. 被引量：1
7Kusaba H,Mitsagi K,Nakarro S,et al.Problems and prospects for combined chemotherapy with 5-FU and low-dose PDD[J].Jpn J Cancer Chemother,1999,26 (11):1575-1580. 被引量：1
8Kubota T.Theoretical basis for low-dose DDP/5-FU therapy[J].Jpn J Cancer Chemother,1999,26(11):1536-1541. 被引量：1
9American Society of Clinical Oncology (ASCO). Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer [ J ]. J Clin Oncol, 1997,15 ( 8 ) :2996 - 3018. 被引量：1
10Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer[J]. N Engl J ned,2002,346(2):92 -98. 被引量：1
